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Pyrroloquinoline quinone is a prominent redox cofactor in
many prokaryotes, produced from a ribosomally synthesized
and post-translationally modified peptide PqqA via a pathway
comprising four conserved proteins PqqB–E. These four pro-
teins are now fairly well-characterized and span radical SAM
activity (PqqE), aided by a peptide chaperone (PqqD), a dual
hydroxylase (PqqB), and an eight-electron, eight-proton oxi-
dase (PqqC). A full description of this pathway has been ham-
pered by a lack of information regarding a protease/peptidase
required for the excision of an early, cross-linked di-amino acid
precursor to pyrroloquinoline quinone. Herein, we isolated
and characterized a two-component heterodimer protein from
the -proteobacterium Methylobacterium (Methylorubrum)
extorquens that can rapidly catalyze cleavage of PqqA into
smaller peptides. Using pulldown assays, surface plasmon reso-
nance, and isothermal calorimetry, we demonstrated the forma-
tion of a complex PqqF/PqqG, with a KD of 300 nM. We created
a molecular model of the heterodimer by comparison with the
Sphingomonas sp. A1 M16B Sph2681/Sph2682 protease. Anal-
ysis of time-dependent patterns for the appearance of proteoly-
sis products indicates high specificity of PqqF/PqqG for serine
side chains. We hypothesize that PqqF/PqqG initially cleaves
between the PqqE/PqqD-generated cross-linked form of PqqA,
with nonspecific cellular proteases completing the release of a
suitable substrate for the downstream enzyme PqqB. The find-
ing of a protease that specifically targets serine side chains is
rare, and we propose that this activity may be useful in pro-
teomic analyses of the large family of proteins that have under-
gone post-translational phosphorylation at serine.
Pyrroloquinoline quinone (4,5-dihydro-4,5-dioxo-1H-pyr-
rolo-[2,3-f]quinoline-2,7,9-tricarboxylic acid (PQQ))3 is a pep-
tide-derived redox quinocofactor, present in several bacterial
dehydrogenases (1). PQQ was initially described in 1964 as the
prosthetic group of a glucose dehydrogenase in Bacterium ani-
tratum (2) and is part of a family of quinocofactors that includes
trihydroxyphenylalanine quinone, tryptophan tryptophylqui-
none, lysyl tyrosine quinone, and cysteine tryptophylquinone.
However, unlike the other members of this family, PQQ is a
freely dissociable cofactor that acts as a noncovalently bound
cofactor for a range of dehydrogenases (3, 4).
PQQ is mainly produced by Gram-negative bacteria, where it
accumulates in the periplasmic space (5) and has been referred
to as a bacterial vitamin (6). PQQ is critical for C1 metabolism
in many microorganisms, whereas other species, such as Esch-
erichia coli, that are unable to produce PQQ autonomously (7)
remain able to obtain this cofactor from the medium (8). Trace
amounts of PQQ have also been detected in mammalian tis-
sues, attributed to dietary sources (9) because mammals appear
incapable of its biosynthesis (10 –14). Early studies showed that
PQQ deficiencies in mice lead to immune system dysfunction,
growth impairment, and abnormal reproductive performance
(15, 16), and the health benefits of PQQ have been attributed to
its antioxidant effects (17). PQQ was recently implicated as a
modulator of mammalian lactate dehydrogenase in vitro (18),
and Saihara et al. (19) reported evidence that PQQ stimulates
mitochondrial biogenesis in mouse fibroblasts.
The dependence of numerous opportunistic pathogens on
PQQ for optimal growth, together with the implied physiolog-
ical and biochemical functions of PQQ (14, 17, 20), make
knowledge of its biosynthetic pathway both timely and impor-
tant. This pathway has been studied since 1987 (21) when the
genes encoding the pathway’s proteins were cloned. PQQ is
derived from a ribosomally produced (PqqA) and post-transla-
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tionally modified peptide (PqqA*), in a series of reactions
involving several enzymes and a peptide chaperone (Fig. 1).
PqqB, PqqC, PqqD, and PqqE are essential and conserved (22),
whereas the protease, usually called PqqF, may or may not be
present in the operon. The biosynthesis of PQQ is initiated by
the formation of a C–C bond between glutamate and tyrosine
residues in PqqA, with the help of the chaperone PqqD, creat-
ing a cross-linked product PqqA* (23). The steps that follow
this reaction include the processing of PqqA* by a protease and
the action of PqqB, which was recently found to be an iron-de-
pendent hydroxylase that installs the quinone moiety of PQQ-
forming AHQQ (24). The last reaction of the pathway is cata-
lyzed by PqqC, the first enzyme to be characterized in this
pathway (25–27). PqqC is a cofactorless oxidase that converts
the isoquinoline heterocycle AHQQ into PQQ, by cyclization
and overall, four stepwise two-electron, two-proton oxidative
reactions.
In recent years this laboratory has turned its attention to the
PQQ biosynthetic pathway in Methylobacterium extorquens
(Mex) AM1 (recently reclassified into a new genus, Methylo-
rubrum (28)), because of the greater access and stability of gene
products from the Mex PQQ operon. The aim of the present
work has been to locate and describe (a requisite) protease for
the scission of the cross-linked di-amino acid from the parent
peptide (Fig. 1). The first and only biochemical characterization
of a designated protease for the PQQ pathway is PqqF from the
-proteobacterium Serratia sp. FS14. Wei et al. (29) crystallized
this protein and assigned it as an M16A peptidase of the ME
clan, characterized as containing the zinc-binding motif
HXXEH (30). Earlier, the Lidstrom group (31) had identified
two gene clusters required for the growth of Mex AM1 mutants
on methanol named pqqDGCBA and pqqEF. The pqqDGCBA
has been shown to correspond to the first five genes of the
Klebsiella pneumoniae operon, pqqABCDE (32). Subsequent
transcriptional regulation studies of growth of Mex on metha-
nol showed induction of both pqqABC/DE and the downstream
cluster (33), supporting an essential role for the latter region
in PQQ production. With the publication of the Mex AM1
genome sequence in 2009 (34), the stretch of DNA correspond-
ing to pqqEF was redefined as encoding two insulinase-like pro-
teins that were classified as M16 proteases. In the present work
we interrogate the two downstream PQQ-linked genes, show-
ing them to encode a two-component peptidase with high
activity toward PqqA, the initial peptide substrate of the PQQ
pathway, from which the putative protease substrate, PqqA*, is
formed by the catalytic action of PqqE with the help of PqqD.
Further sequence alignment and three-dimensional threading
indicate that PqqF/PqqG belong to the protease M16B family.
A major unexpected result is the high specificity of cleavage by
PqqF/PqqG at serine, a property that may provide a new pro-
teomic tool for the analysis of post-translational modification
of protein serine side chains in vivo.
Results
Cloning and expression of Mex pqqF and pqqG
The region of the Mex genome reported as pqqEF was ori-
ginally annotated as a 709-amino acid protein (tentatively
assigned to pqqE) together with a 219-amino acid protein
(pqqF, sharing identity with endopeptidases) (31, 35). In this
work we resequenced the part of the Mex genome where these
genes are located and confirmed the presence of two ORFs
encoding insulinase-like proteins, one with 460 amino acids
(PqqF, accession number WP_003599161.1) and one with 427
amino acids (PqqG, accession number WP_003599163.1) (Fig.
2 and Table S1). The indicated PqqF and PqqG were cloned
from Mex and expressed as His6 tag fusions in E. coli, yielding
soluble protein fractions in both instances. Isolation by affinity
Figure 1. The proposed PQQ biosynthetic pathway in M. extorquens. Activity has been confirmed for PqqD/PqqE (23, 38) and PqqC (25). The reaction
catalyzed by PqqB has been inferred using substrate analogs (24).
A two-component protease targeting serine side chains
15026 J. Biol. Chem. (2019) 294(41) 15025–15036
chromatography on nickel columns led to good yields of homo-
geneous proteins: 25–30 mg/liter medium in the case of His6-
PqqF and 11–24 mg/liter medium in the case of His6-PqqG.
The His6 tags were removed by treatment with thrombin, and
protein was further purified by size exclusion chromatography
(in the case of PqqF) or affinity chromatography on a nickel
column (in the case of PqqG). In all cases, the samples were
analyzed by SDS-PAGE and by MS to confirm the protein iden-
tity and the purity (see Fig. S1 for an example of a gel of purified
His-tagged and nontagged PqqF and PqqG).
The interaction of Mex PqqF and PqqG
We interrogated the possibility of complex formation
between PqqF and PqqG, by analogy to the interaction of TldD
with TldE described by Ghilarov et al. (36). We first used pull-
down assays to investigate the protein–protein interaction (37).
His6-PqqF was immobilized in a nickel affinity column and
served as the “bait” protein. PqqG, the “prey” protein, was then
passed through the column, and the flowthrough was examined
by SDS-PAGE. Controls without bait and without prey were
performed, and the aggregate results are shown in Fig. 3. Com-
paring lanes 7 and 8, it is clear that PqqG is immobilized in the
column only when His6-PqqF is present (lane 7, no PqqG in the
flowthrough). Both proteins are eluted when imidazole is added
to the buffer (lane 11).
After observing this qualitative interaction between PqqF
and PqqG, we pursued the dissociation constant (KD) for com-
plex formation. Initially, surface plasmon resonance (SPR) was
employed, because this method requires minimal protein mate-
rial, and our lab has had previous success with the technique
(38). However, when His6-PqqG was immobilized to a nickel–
nitrilotriacetic acid gold chip, there was a concentration-de-
pendent, nonspecific absorption of PqqF, which was apparent
from the blank subtracted SPR response not returning to base-
line (Fig. S2). Likewise, when His6-PqqF was immobilized to the
chip, we observed nonspecific absorption of PqqG to the chip,
albeit less severely.
We next turned to isothermal calorimetry (ITC), in which
His6-PqqG was titrated by a concentrated stock of His6-PqqF
and the heat change compared with controls where either His6-
PqqF or His6-PqqG were replaced by dialysis buffer. Thermo-
grams were obtained in triplicate, leading to a fitted KD for the
PqqF/PqqG complex of 300  70 nM, with an estimated molar
ratio of 1:1 (Fig. 4). This submicromolar KD value suggests that
the PqqF/PqqG complex will form in vivo via a strong transient
(or permanent) interaction (39).
Proteolytic activity of PqqF/PqqG toward PqqA.
Because of a limited availability of chemically synthesized
Mex PqqA, our experimental strategy was to screen broadly for
enzyme activity using either separate samples of PqqF or PqqG
or a 1:1 complex of these two proteins. The mass spectrometry–
based assays for loss of PqqA as a function of time are presented
in Fig. 5A. As shown, PqqA remains undigested for up to 1 h
after incubation with PqqG alone. By contrast, PqqF alone or in
complex with PqqG gives rise to 50 and 90% cleavage after 10
min, respectively. From Fig. 5B, it can be seen that, at the high
levels of enzyme used in the present study, an initial 2-fold
increase in the PqqF/PqqG complex increases the rate of PqqA
cleavage 2-fold and then levels off.
The rapid hydrolysis of PqqA in the presence of PqqF/PqqG
is striking, and future structure–function analyses are being
developed for assays of recombinantly produced PqqA and ana-
logs thereof, and the cross-linked peptide PqqA* derived from
the action of PqqE/PqqD. Testing an available truncated ver-
sion of PqqA, EVTSY, containing the Glu and Tyr side chains
that undergo cross-linking by PqqE (Fig. 1), we find a very slow
and incomplete hydrolysis for up to 4 h, approximating only 1%
of the initial substrate (Fig. 6).
We next turned to an analysis of the time and positional
dependence of products released from the full-length PqqA in
the presence of PqqF/PqqG. We focused on the higher intensity
peaks, corresponding to peptide products whose percentage
abundance was more than 3%, and obtained the results shown
in Fig. 7. Analysis of the formed peptide products indicates a
preference of the PqqF/PqqG complex for serine residues, at
Ser–Glu, Ser–Val, Ser–Tyr, and Glu–Ser and less efficiently at
Thr-Ser. The most rapid appearance of an N-terminal peptide
product KWAAPIVSEIS indicates an initial cleavage at Ser11-
Val12; note that the native peptide has Cys at position 11 and is
not expected to be cleaved between amino acids at positions 11
and 12. This is followed by cleavage of Ser8-Glu9 yielding
KWAAPIVS, concomitant with a decrease in the abundance of
KWAAPIVSEIS (Fig. 7A). After 10 min, central peptides such
as VGMEVTS, VGMEVTSYE, and VGMEVT are detectable, a
consequence of the cleavage at Ser11-Val12, as well as cleavage
at Ser18-Tyr19, Glu20-Ser21, and Thr17-Ser18 (Fig. 7B). The
C-terminal peptides YESAEIDTFN and SAEIDTFN are also
detected (Fig. 7C). Cleavages at Val7-Ser8, Ile10-Ser11, and
Ser21-Ala22 do not seem to happen rapidly or at all, because the
corresponding peptides were not detected for up to 4 h (results
not shown). Taken together, these results suggest the targeting
of Mex PqqF/PqqG to both N- and C-terminal serine side
chains with a likely preference for hydrogen bonding and/or
negatively charged flanking side chains (Fig. 7D). The one
instance in which cleavage occurred adjacent to a hydrophobic
side chain was for a nonnative Ser site (position 11 in which Cys
was replaced by Ser in the synthetically prepared peptide
substrate).
Figure 2. Arrangement of the PQQ biosynthesis protein– encoding genes in the Mex genome. The numbers indicate the basepair position in the genome.
A denotes pqqA, the gene encoding the peptide precursor. pqqF and pqqG encode the proteins characterized in this paper.
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Structural modeling of the PqqF/PqqG heterodimer
The M16 family of peptidases is subdivided into M16A,
M16B and M16C (40), depending on the different domain orga-
nization in these peptidases (Fig. 8). A template for comparative
structural modeling of the Mex PqqF/PqqG heterodimer was
identified based on sequence similarity to the heterodimeric
M16B protease comprised of Sph2681/Sph2682 from Sphin-
gomonas sp. A1 (PDB code 3amj). These two monomers, dis-
playing 41 and 32% sequence identity, respectively, with PqqF
and PqqG, were the highest rated polypeptides of known struc-
ture. The best comparative model of the PqqF/PqqG het-
erodimer shows a high degree of structural similarity toward
the template structure (root mean square deviation of 0.96 Å for
the aligned carbon  atoms; Fig. 9A). In Fig. 9B, a close-up of the
zinc center highlights the coordinating histidines and the cata-
lytic R/Y pair on the B chain. The residue orientation is nearly
identical in the template and target. Zinc analyses of the as-iso-
lated proteins using ICP have shown that in the absence of any
reconstitution PqqG is metal-free and that PqqF binds Zn2
(0.2 M).
The diversity of PQQ proteases in proteobacteria
In light of the present results, we proceeded to survey anno-
tated PQQ-producing bacterial species for additional examples
of the presence of PqqF and/or PqqG in pqq operons (Table S2).
In the case of -proteobacteria like Mex, we observe that genes
for the two-component PqqF/PqqG system are located outside
of the major portion of the pqq operon, either upstream or
downstream (Fig. S3). On the other hand, -proteobacteria spe-
cies possess an M16A-like peptidase comprised of a single-
chain protein with two tandem domains of 500 amino acids
each, and a less conserved HXXEH zinc-binding site (analogous
to the PqqF found in the pqq operon of K. pneumonia (41)).
This ORF can be located either within or outside the major pqq
operon (Fig. S3). It is interesting to note that we did not locate
any -proteobacteria species containing pqqF within their
pqq operon, even in the case of species with an M16A PqqF of
Figure 3. Interaction between PqqF and PqqG detected by pulldown assays in an affinity nickel column (His SpinTrapTM). Lanes 1 and 9, protein ladder
(10 –200 kDa). Lane 2, bait protein, His6PqqF. Lanes 3 and 5, flowthrough of His6PqqF. Lane 4, flowthrough of buffer from column without bait. Lane 6, prey
protein, PqqG. Lanes 7 and 10, flowthrough of PqqG solution through column with bait. Lane 8, flowthrough of PqqG solution through column without bait.
Lanes 11, 12, and 13, elution with 250 mM imidazole from columns shown in lanes 7, 8, and 5, respectively. MW, molecular mass.
Figure 4. Binding of PqqF and PqqG observed by ITC. The representative
raw isotherm traces (top panel) and the integral data points (bottom panel) are
shown for an experiment with His6PqqF and His6PqqG (black). Controls with
just His6PqqF (cyan) and just His6PqqG (gray) are also shown. As discussed
under “Experimental Procedures,” both proteins were dialyzed in the same
container against 50 mM Tris, pH 8, 300 mM NaCl. In a typical experiment, a
sample of 20 M His6-PqqG was titrated with a concentrated stock (200 M) of
His6-PqqF. The first injection for each experiment was omitted in the data
analysis. The thermograms were analyzed by the companion software Nano-
Analysis (TA Instruments), and the single-site model fitted curve generated
from the experimental data is shown in red. A Kd of 300  70 nM was obtained
from triplicate assays.
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similar size to the ones found in most -proteobacteria (e.g.
Acetobacter pasteurianus, Agrobacterium radiobacter, and
Gluconoacetobacter diazotrophicus; Table S2). The sequence
alignments of several PqqF from -proteobacteria (Fig. S4) and
-proteobacteria (Fig. S5) clearly show the M16B and M16A sig-
natures, respectively (Fig. 8). In the case of -proteobacteria, an
alignment of the PqqG sequence shows the RY region (Fig. S6)
commonly found in the C terminus of the M16A PqqF from
-proteobacteria (Fig. S5B).
Discussion
The biosynthesis of PQQ has been studied since the late
1980s (42), but a complete understanding of the details of the
pathway has been elusive. The PQQ operon was identified in
1987 (21), and shortly afterward two independent groups
showed that the amino acids tyrosine and glutamate contrib-
uted all of the carbon and nitrogen atoms within the final cofac-
tor structure (43, 44). Goosen et al. (45) identified a gene encod-
ing a 24-amino acid peptide (later called PqqA) as the precursor
of PQQ biosynthesis in Acinetobacter calcoaceticus. The PqqC
structure and function were solved in 2004 (27, 46), and PqqD
was later shown to be a peptide chaperone interacting with
PqqA and PqqE (38), a radical SAM enzyme (47). Although
PqqE had been the candidate for the catalysis of the carbon-
carbon bond formation between tyrosine and glutamate, evi-
dence for this reaction did not appear until 2016, together with
the elucidation of the critical role played by PqqD (23). With the
recent discovery that PqqB is an iron-dependent hydroxylase
(24), only the role of an essential protease remained unknown.
Previous work showed that PqqF is necessary for PQQ produc-
tion in Pseudomonas aeruginosa (48) and Serratia sp. FS14 (29).
However, other reports indicated that PqqF did not seem to be
essential for PQQ biosynthesis in select microorganisms (31).
This feature, as well as the fact that PqqF is not uniformly pres-
ent in the pqq operon (22, 31), has made identification of pro-
teases targeted to PQQ biosynthesis difficult.
This study shows that in Mex AM1, the primary microorgan-
ism currently used by our group to study the PQQ biosynthetic
pathway, two proteins, PqqF and PqqG, encoded by separate
genes located downstream of the main pqq operon (Fig. 2),
interact to form a M16B heterodimer (Figs. 3 and 4) that cata-
lyzes the proteolysis of PqqA (Fig. 5). The pqqF and pqqG genes
are different from the ones initially described by Springer et al.
(31). Several prokaryotic M16B peptidases have been predicted
based on sequence alignment (49), and Maruyama et al. (50)
reported the first heterodimeric M16B peptidase similar to the
one presented here, in Sphingomonas sp. A1. Our observation
of activity for PqqF alone is in contrast with what was observed
for the Sphingomonas sp. A1 Sph2681, one of the subunits of
the heterodimer on which we modeled PqqF/PqqG (Fig. 9).
Unlike Mex PqqF, Sph2681 with 41% sequence identity does
not exhibit any peptidase activity by itself (50). The het-
erodimer Sph2681–Sph2682 is active toward several peptides
and proteins from 5 to 51 amino acid residues, with maximum
specific activity obtained for a 31-mer -endorphin substrate.
Figure 5. Activity of PqqF and/or PqqG with PqqA(C11S) monitored by
PqqA disappearance via MS. All assays were performed in autoclaved 50
mM Tris-HCl, 300 mM NaCl, pH 8.0 buffer at room temperature. A, effect of
individual enzymes and the enzyme complex. The concentration of PqqF and
PqqG (1:1) was 2 M, whereas PqqA was 20 M. B, effect of enzyme concen-
tration. PqqF and PqqG were used at the indicated concentrations, and PqqA
was at 20 M. The area highlighted in a rectangle clearly shows that there is an
effect of the enzyme concentration on the initial reaction rate. In all experi-
ments, a control of PqqA in buffer was performed, and the PqqA relative
abundance was determined by a mass spectrometric assay, as previously
described (23). All results shown are from a representative data set.
Figure 6. Activity of PqqF and/or PqqG with the short PqqA subpeptide
EVTSY. The assays were performed in autoclaved 50 mM Tris-HCl, 300 mM
NaCl, pH 8.0 buffer at room temperature. The concentration of PqqF and
PqqG was 2 M, and the concentration of EVTSY was 20 M. Note that the y
axis is greatly expanded and that the maximum amount of the product EVS is
1% obtained after a 250-min incubation. In all experiments, a control of
EVTSY in buffer was performed, and the relative abundance of EVTSY and
possible ion products was determined by the mass spectrometric assay pre-
viously described (23). The results shown are from a representative data set.
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MALDI-TOF analyses of the proteolyzed products suggest a
random cleavage of the peptide/protein substrates (50).
Despite the above differences in activity and specificity and
an average of 35% sequence identity, we have constructed a
comparative model of the PqqF/PqqG heterodimer based on
the Sphingomonas sp. protease structure (Fig. 9). It can be seen
that there is a high structural similarity between the two het-
erodimers, supported by good quality assessment indicators for
the model and pointing to a reliable 3D prediction. Although
based on the closed dimer structure present in the 3amj PDB
file (chains AB) of the Sphingomonas sp. protease, model
building shows it is possible to also fit the monomers to the
open conformation (3amj, chains C  D). In this conformation,
a likely entry point for the cross-linked substrate PqqA* is made
evident (see Fig. S7). We note that an estimate of theoretical
binding energies for the formation of a closed conformation
dimer of PqqF/PqqG (data not reported) are in reasonable
agreement with the experimental KD for the binding of PqqF to
PqqG obtained herein (Fig. 4).
From activity assays (Figs. 5 and 7), a chemically synthesized
form of PqqA (identical to the native peptide with the exception
of C11S) is concluded to be a robust substrate for PqqF/PqqG.
Activity was followed by the decrease in PqqA abundance and
the formation of peptide products, monitored by MS. Although
PqqF is capable of some proteolytic activity with PqqA, the
reaction catalyzed by PqqF/PqqG is much faster, with a signif-
icant decrease in the abundance of PqqA seen at t  0, when
both proteins are present (Fig. 5A). Increasing the protein con-
centration increases the reaction rate (Fig. 5B), but initial rate
studies will be needed to obtain quantitative results for initial
rates versus catalyst concentration. This is expected to become
possible once recombinant levels of PqqA are available and/or
via modification of the assay that currently involves reaction
quenching and product analysis by MS. The heterodimer did
not catalyze the cleavage of the short substrate analog EVTSY
(Fig. 6) to a significant extent, showing either a role for flanking
amino acids for efficient hydrolysis and/or a requisite precursor
relationship in cleavage.
Using the synthesized PqqA (C11S), mainly seven proteolytic
products were detected by MS: the N-terminal peptides
KWAAPIVSEIS and KWAAPIVS; central peptides products
VGMEVTS and VGMEVTSYE and, at lower abundance,
VGMEVT; and the C-terminal peptides YESAEIDTFN and
SAEIDTFN. Taking these results together, a pattern of cleavage
at serine residues emerged, as shown in Fig. 7D. The biologi-
cally relevant substrate of the protease is expected to be the
cross-linked PqqA* product from the activity of PqqE, with the
presence of a peptide chaperone (PqqD) facilitating cross-link-
ing while possibly protecting the underivatized peptide from
Figure 7. Main peptide products derived from the activity of PqqF/PqqG on PqqA. A, N terminus peptides. B, central peptides. C, C terminus peptides. D,
suggested cleavage pattern by PqqF/PqqG. The results shown are from a representative data set.
Figure 8. Differences between domain organization in metallopepti-
dases M16A, M16B, and M16C. A, the M16.019/nonpeptidase homolog
heterodimer of the M16B subfamily, which is the arrangement found in
PqqF/PqqG. B, single chain fusion of two tandem domains connected by a
short hinge loop (in black) that characterizes the M16A and M16C subfam-
ilies. The M16A arrangement is widely distributed among PqqF found in
-proteobacteria.
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hydrolysis in vivo (Fig. 1). We hypothesize that one of the main
products when using the cross-linked product from native Mex
PqqA will be: , where the asterisks denote the
cross-linked residues Glu and Tyr. Subsequent trimming from
the N and C termini will be required (via catalytic activity of
additional protease(s)) to generate the unadorned cross-linked
diamino acid as the postulated substrate of PqqB (Fig. 10).
According to MEROPS, the Peptidase Database (https://
www.ebi.ac.uk/merops) (69),4 171 known and putative pepti-
dases and 36 nonpeptidase homologs have been identified in
Mex AM1, and 56 of these are unassigned peptidases of
unknown function. Thus, there are several potential candidates
for the catalytic activity required to further process the peptide
obtained from the activity of PqqF/PqqG. Interestingly, -pro-
teobacteria seem to be rich in prokaryotic caspase homologs,
termed metacaspases (51) and, more recently, orthocaspases
(52). These homologs are structurally and functionally diverse
and might have roles not only in programmed cell death but
also on signaling, enzyme catalysis, and protein modification
(51). Caspases were initially thought to be highly specific to
cleave after aspartic acid residues, but the work by Seaman et al.
(53) suggested that these proteases can also cleave after glu-
tamic acid residues (note that the putative additional cleavages
of our peptide are at E residues) and, rarely, at phosphoserine
residues. Using MEROPS, we identified one protease of the
caspase family (clan PA, family S1) in Mex, but it has not been
biochemically characterized. In summary, further work will be
needed to identify the enzyme(s) responsible for the further
trimming of the peptide, but several candidates are available in
the Mex genome.
Currently, our group is optimizing the kinetics of formation
of the cross-linked product PqqA* (catalyzed by PqqE in the
presence of the chaperone PqqD), to obtain material in high
yield and purity for further testing and activity comparison with
PqqF/PqqG, especially concerning the reaction products. Addi-
tionally, we are developing a recombinant method to obtain a
stable, nondimerizing PqqA that retains Cys at position 11.
Looking to the future, the highly unexpected observation of a
protease with specificity toward serine side chains at both the C
and N termini of a peptide is of considerable possible interest.
This type of selectivity, which is rarely observed in biology (54),




All restriction enzymes, the Phusion polymerase, T4 DNA
ligase, and the protein ladder for SDS-PAGE were obtained
from New England Biolabs (Ipswich, MA). All oligonucleotide
primers were purchased from Eurofins Genomics (Louisville,
KY). DNA was sequenced by the University of California
Sequencing Facility (Berkeley, CA). The peptide PqqA (Uni-
prot number Q49148) was synthesized by CPC Scientific
(Emeryville, CA) as KWAAPIVSEISVGMEVTSYESAEIDTFN,
with Ser substituting for Cys11 to avoid possible dimer forma-
tion. A control subpeptide, containing the Try and Glu residues
involved in PqqA cross-link (EVTSY), was synthesized by the
same company.
PqqF and PqqG cloning strategies
The genome portion containing the two genes of interest,
2,400,880 to 2,403,819 bp, was amplified from Mex AM1
genomic DNA (DSMZ, Braunschweig), using different com-
binations of primer pairs Mex_seq_Fwd1–4 and Mex_seq_Rev1–2
(Table 1) and sequenced. After identifying the genes encoding
the putative Mex proteases PqqF and PqqG, these were ampli-
fied from the same genomic DNA, using the PqqF_Clon and
PqqG_Clon primer set (Table 1) with the Phusion polymerase
system. The PCR products were cloned into pET28a vectors
(Novagen) using the NheI and HinIII restriction sites. The plas-
mids were transformed into E. coli XL1 Blue competent cells
(Stratagene) and selected on LB agar with 50 g/ml kanamycin
(LBKan50). The plasmids harboring the correct constructs,
His6-PqqF and His6-PqqG, were cotransformed into E. coli
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
Figure 9. Structural model of the PqqF/PqqG heterodimer. A, alignment of the model (PqqF in gold and PqqG in blue) with the template structure (Sph2681
in green and Sph2682 in gray) with a root mean square deviation of 0.96 Å for PqqF/Sph2681 and 1.65 Å for PqqG/Sph2682. B, close-up of the metal center,
showing the coordinating residues (gold and green), catalytic R/Y (blue and gray), and putative catalytic base (red and pink). The zinc ion is in teal.
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BL21-CodonPlus(DE3)-RIPL competent cells (Agilent) and
also selected on LBKan50.
Protein expression and purification
The His-tagged proteins were expressed in Terrific broth
with 50 g/ml kanamycin (TBKan50) supplemented with 10
M ZnSO4. The cultures were grown at 37 °C, 220 rpm until an
A600  0.8, and protein expression was induced with isopropyl
-D-1-thiogalactopyranoside (final concentration, 100 M).
Expression proceeded for 22 h at 17 °C, 220 rpm, and afterward
the cells were harvested by centrifugation, and the pellets were
frozen at 80 °C until use. Protein purification was done by
affinity chromatography using His60 nickel Superflow (Clon-
tech) columns. The cell pellets were resuspended in lysis buffer
(50 mM Tris-HCl, pH 8.8, 300 mM NaCl, 10% (v/v) glycerol, 1
mM phenylmethylsulfonyl fluoride) and lysed by sonication on
ice, and the cell-free extracts were obtained by centrifugation of
the lysates. The extracts were loaded into the columns previ-
ously equilibrated with lysis buffer, and the columns were
sequentially washed with buffer containing 5 and 20 mM imid-
azole, respectively, to remove nontagged proteins, and finally
the tagged proteins were eluted with buffer containing 250 mM
imidazole. The desired fractions were pooled and dialyzed
overnight against 50 mM Tris-HCl, pH 8.8, 300 mM NaCl, 10%
(v/v) glycerol at 4 °C. The dialyzed protein solutions were con-
centrated as needed, aliquoted, and flash frozen in liquid nitro-
gen. Protein concentration and purity were monitored along
the process by absorbance at 280 nm, by the Bradford assay
(55), and by SDS-PAGE using the method of Laemmli (56).
MS of the native and digested proteins
Small volumes (1.5 ml) of the purified protein solutions
(predialysis) were buffer exchanged over PD-10 columns (GE
Healthcare) pre-equilibrated with 50 mM Tris-HCl, pH 8.8, 300
mM NaCl, to remove the glycerol and imidazole. Aliquots, with
a concentration of 30 M, were used for intact protein MS.
The remaining volume was concentrated by centrifugal ultra-
filtration in an Amicon Ultra4 10K (Millipore). The protein was
denatured by incubation with urea and DTT at 55 °C for 15 min
and then digested with trypsin (in a concentration less than 50
times that of the protein being digested) in 50 mM Tris-HCl, pH
8.0, 300 mM NaCl, 1 mM DTT, and 1 mM CaCl2, at room tem-
perature for 4 h. Samples of intact and digested proteins were
Figure 10. Downstream region of the PQQ biosynthetic pathway showing the predicted proteolytic steps catalyzed by PqqF/PqqG (described in this
work) and other possible proteases.
Table 1
Primers used in the amplification and sequencing procedures
NA, not applicable.






Mex_seq_Fwd1 ATCTCGGCGGGTCGGCGAAG 68.6 NA
Mex_seq_Fwd2 CGCGACGTGGTGCTGGAGGA 68.6 NA
Mex_seq_Fwd3 GAGGGCGTGACCCTGGAGGCC 72.3 NA
Mex_seq_Fwd4 CGGGCGATCTCGACTCGGAT 66.6 NA
Mex_seq_Rev1 GCCGTGATGGAATTGGTGGAA 62.6 NA
Mex_seq_Rev2 CACGAACAGCGAGGCGGACA 66.6 NA
PqqF_clon_Fwd aatagctagcATGCACCTCTACCGGAAGGCC 66.5 NheI
PqqF_clon_Rev taaaagcttATCAGGGCCGTCTCAGGCGAT 66.5 HindIII
PqqG_clon_Fwd aatagctagcATGAATCTCGCCGAGACCGG 64.5 NheI
PqqG_clon_Rev taaaagcttCTACAGCCCCGTGGGCCG 69.0 HindIII
PqqF_seq_Fwd ATGCACCTCTACCGGAAGGCC 66.5 NA
PqqF_seq_Rev ATCAGGGCCGTCTCAGGCGAT 66.5 NA
PqqG_seq_Fwd ATGAATCTCGCCGAGACCGG 64.5 NA
PqqG_seq_Rev taaaagcttCTACAGCCCCGTGGGCCG 69.0 NA
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analyzed using Synapt and Orbitrap mass spectrometers,
respectively, as described previously (57, 58).
Cleavage of His6 tag with thrombin
His6-tagged protein samples were defrosted on ice and incu-
bated with biotinylated thrombin (Novagen), 2 units of throm-
bin/mg of tagged protein for 16 h at 14 °C in the buffer provided
by the supplier. Streptavidin-agarose (Novagen) was then
added to remove the thrombin, and the mixture was gently
shaken for 30 min at room temperature and transferred to
0.45-m cellulose acetate centrifugal microfilters (GVS Life
Sciences) to separate the filtrate. The untagged PqqG was sep-
arated from the cleaved His tag and the uncleaved enzyme by
passing the mixture through a His60 nickel Superflow (Clon-
tech) column and collecting the flowthrough. The untagged
PqqF was found to nonspecifically interact with the nickel col-
umn and had to be recovered by size-exclusion chromatogra-
phy on a HiPrep 16/60 Sephacryl S-200 High resolution column
(GE Healthcare) outfitted to an AKTA FPLC (GE Healthcare)
with a flow rate of 0.5 ml/min at 4 °C. The mobile phase was 20
mM Tris-HCl, 0.15 M NaCl, 5% (v/v) glycerol, and the elution
was monitored by absorbance at 280 nm. The fractions contain-
ing protein were collected and analyzed by SDS-PAGE, and the
ones containing the untagged enzymes were pooled and con-
centrated by ultrafiltration (Amicon Ultra15 30 kDa). The sam-
ples were analyzed by native MS, as described previously, and
the concentration was determined by absorbance at 280 nm.
ICP optical emission spectroscopy analysis
The analysis of zinc content in as purified His tag– cleaved
PqqF (10 and 20 M) was performed in at least triplicate using a
PerkinElmer 5300 DV optical emission ICP instrument. Metal
concentration was determined from a calibration curve for
zinc, prepared from dilution of a zinc ICP standard stock solu-
tion (Sigma–Aldrich).
Protein interaction assays
Pulldown assays in nickel column—The interaction between
PqqF and PqqG was studied by a pulldown assay using His
SpinTrapTM columns (GE Healthcare) with a bed volume of
100 l, using His6-PqqF (75 nmol) as the bait immobilized in
the column and PqqG as the prey. The binding buffer was 20
mM Tris-HCl, pH 8.0, 0.15 M NaCl, 5% (v/v) glycerol; the wash
buffer contained 10 mM imidazole; and the elution buffer had
250 mM imidazole. A nontreated column control was also run
to identify and eliminate false positives caused by nonspecific
binding of PqqG, as well as a control with bait (His6-PqqF) but
no prey (PqqG).
SPR measurements—The interaction between PqqF and
PqqG was also studied by SPR using an nitrilotriacetic acid-
functionalized Dextran gold chip installed on a Biosensing
Instruments BI4500 SPR instrument (Biosensing Instruments,
Tempe, AZ). The temperature was set to 20 °C, and a flow rate
of 60 l/min was used for all experiments. The chip was pre-
treated with EDTA and a nickel solution, followed by immobi-
lization of His6-PqqF. Following a 60-s wash step, native PqqG
in concentrations from 45 nM to 3 M was injected as the ana-
lyte. Following each binding experiment, immobilized His6-
PqqF was striped with EDTA and reimmobilized prior to the
next binding experiment. Experiments were run in triplicate,
and the response from a reference cell without bound PqqF was
subtracted. The data were analyzed using the accompanying
SPR software.
Isothermal titration calorimetry—The dissociation constant
between His6-PqqG and His6-PqqF was measured by ITC, in
triplicate, using a NanoITC (TA Instruments). Purified His6-
tagged enzymes were dialyzed in the same container against 50
mM Tris, pH 8.0, 300 mM NaCl. In a typical experiment, the
sample cell was loaded with 20 M His6-PqqG and titrated with
one injection of 1 l containing 200 M His6-PqqF, followed by
15 more injections at 2.98 l. The reference cell contained
degassed deionized water. Control experiments were run iden-
tically except His6-PqqF or His6-PqqG was replaced by dialysis
buffer. The collected thermograms were analyzed by the com-
panion software, NanoAnalysis (TA Instruments). The data
were baseline-subtracted and fitted to an independent model.
All first injections were removed from data analysis.
Activity assays
The solution of chemically synthesized PqqA was freshly
prepared in MilliQ water. The materials and buffer (50 mM
Tris-HCl, pH 8.0, 300 mM NaCl) used in these assays were auto-
claved to avoid contaminating protease interference. To check
for the purity and stability of PqqA, controls of PqqA by itself, in
the presence of zinc and EDTA were performed. The activity
was followed by determination of the percentage of abundance
of PqqA as a function of time, measured by LC-MS. PqqF
and/or PqqG were incubated for 10 min on ice, with or without
added zinc. Unless specified otherwise the concentrations of
enzymes were 2 M, and PqqA was added to a final concentra-
tion of 20 M. The reactions were kept at room temperature,
and samples were collected at 0, 10, or 60 min and, in some
cases, 240 min and were quenched with 5% (v/v) formic acid,
immediately frozen in liquid nitrogen and stored at 80 °C.
The activity was also tested with the small subpeptide EVTSY
that contains the amino acid precursors to PQQ (Glu and Tyr).
Mass spectrometry assay
The samples quenched with formic acid were defrosted and
centrifuged at 10,000 rpm for 10 min at 4 °C. The supernatants
were analyzed using an Orbitrap mass spectrometer, as
described previously (23).
Computational methods
Bioinformatics analysis—We checked the pqq operon in the
genomes of the bacterial species reported by Shen et al. (22) to
detect M16 peptidases, using the NCBI database RefSeq (59).
The retrieved protein sequences were separated into M16B and
M16A peptidases and were aligned using Clustal Omega, which
was also used to calculated identity percentages (60). Align-
ment figures were obtained and annotated with Jalview (61).
Comparative modeling of the PqqF/PqqG dimer—A suitable
template for the PqqF/PqqG putative heterodimer was found
by searching for sequence homologs on the UNIPROT subset
of protein of known structure. The highest-ranking candidate
was the M16B metallopeptidase heterodimer from Sphingomo-
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nas sp. with PDB code 3amj. The two sequences in this dimer,
Sph2681 and Sph2682, display, respectively, 41 and 32% iden-
tity with PqqF and PqqG; at this level of identity good compar-
ative models can usually be built with confidence (62). Also,
Sph2681 contains the conserved HXXEH zinc-binding motif,
and Sph2682 contains the R/Y catalytic pair, like PqqF and
PqqG (Figs. S4 and S6). Based on this template, comparative
models were generated for the target using the MODELLER
software (63). Run input files were prepared for MODELLER,
taking into consideration the presence of the Zn2 ion in the
PqqF chain. To ensure the correct placement of the metal in the
models, harmonic restraints were applied based on the coordi-
nation geometry observed in the 3amj structure. A total of 60
models were produced with very stringent optimization and
refinement MODELLER parameters (maximum variation iter-
ations 300, automatic scheduling slow, two repeat cycles, and
the “very slow” refinement protocol). The model showing the
best (lowest) DOPE score (64) was selected as the starting point
to produce 10 models with automatic loop refinement. Best
models were selected combining the normalized Z-DOPE and
Swissprot QMEAN4 scores (65). These models were further
analyzed with the WHATCHECK, PROSA, and MolProbity
tools, revealing several steric clashes and outlier values for some
bond distances and angles. To alleviate this situation, the final
models were energy-minimized with the GROMACS software
(66) using the Gromos54a7 forcefield (67). The minimized
model showed marked improvement, producing a near-native
MolProbity score and a QMEAN score of 1.6. This model was
also checked with the ModFOLD6 server (68), producing an
overall score 0.518 and a p value of 4.6  105 (indicative of a
high-quality model).
Author contributions—A. M. M., I. B., and J. P. K. conceptualization;
A. M. M., J. A. L., P. J. M., and J. P. K. formal analysis; A. M. M. and
J. P. K. writing-original draft; A. M. M., J. A. L., P. J. M., I. B., A. T. I.,
and J. P. K. writing-review and editing; A. T. I. methodology; J. P. K.
supervision.
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